A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial Article Early Access

Industry Collaboration

cited authors

  • Spigel, David R.; Shipley, Dianna L.; Waterhouse, David M.; Jones, Suzanne F.; Ward, Patrick J.; Shih, Kent C.; Hemphill, Brian; McCleod, Michael; Whorf, Robert C.; Page, Ray D.; Stilwill, Joseph; Mekhail, Tarek; Jacobs, Cindy; Burris, Howard A., III; Hainsworth, John D.

authors

Publication Date

  • August 16, 2019

webpage

published in

category

keywords

  • Heat-shock protein 27
  • Non-small cell lung cancer
  • Oligonucleotide